Symbol:
Cul9
Name:
cullin 9
RGD ID:
1562008
Description:
Predicted to enable transferase activity; ubiquitin protein ligase binding activity; and zinc ion binding activity. Predicted to be involved in microtubule cytoskeleton organization; protein ubiquitination; and regulation of mitotic nuclear division. Predicted to be located in cytosol. Predicted to be part of cullin-RING ubiquitin ligase complex. Orthologous to human CUL9 (cullin 9); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
cullin-9; LOC316228; p53-associated parkin-like cytoplasmic protein; Parc; RGD1562008; similar to p53-associated parkin-like cytoplasmic protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CUL9 (cullin 9)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Mus musculus (house mouse):
Cul9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Cul9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CUL9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CUL9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cul9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CUL9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CUL9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Cul9 (cullin 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
CUL9 (cullin 9)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Cul9 (cullin 9)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
cul9
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 9 21,933,699 - 21,977,145 (+) NCBI GRCr8 mRatBN7.2 9 14,435,948 - 14,479,552 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 9 14,436,111 - 14,479,548 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 9 23,019,900 - 23,063,207 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 9 28,082,972 - 28,126,214 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 9 26,383,281 - 26,426,587 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 9 16,747,449 - 16,844,033 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 9 16,747,662 - 16,844,057 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 9 15,652,541 - 15,745,381 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 9 9,800,224 - 9,863,348 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 9 12,185,789 - 12,227,563 (+) NCBI Celera Cytogenetic Map 9 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cul9 Rat 1,2-dimethylhydrazine decreases expression ISO Cul9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CUL9 mRNA CTD PMID:22206623 Cul9 Rat 17beta-estradiol increases expression ISO Cul9 (Mus musculus) 6480464 Estradiol results in increased expression of CUL9 mRNA CTD PMID:39298647 Cul9 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUL9 mRNA CTD PMID:21215274 Cul9 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CUL9 mRNA CTD PMID:33387578 Cul9 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CUL9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CUL9 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:28628672 Cul9 Rat 4,4'-sulfonyldiphenol multiple interactions ISO CUL9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:28628672 Cul9 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:36041667 Cul9 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Cul9 (Mus musculus) 6480464 bisphenol S results in decreased methylation of CUL9 exon and bisphenol S results in decreased methylation of CUL9 promoter CTD PMID:33297965 Cul9 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CUL9 mRNA CTD PMID:30047161 Cul9 Rat acrylamide decreases expression ISO CUL9 (Homo sapiens) 6480464 Acrylamide results in decreased expression of CUL9 mRNA CTD PMID:32763439 Cul9 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of CUL9 mRNA CTD PMID:30047161 Cul9 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CUL9 mRNA CTD PMID:30779732 Cul9 Rat arsenite(3-) multiple interactions ISO CUL9 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CUL9 mRNA] CTD PMID:32406909 Cul9 Rat beryllium sulfate increases expression ISO CUL9 (Homo sapiens) 6480464 beryllium sulfate results in increased expression of CUL9 mRNA CTD PMID:35679967 Cul9 Rat beryllium sulfate decreases expression ISO CUL9 (Homo sapiens) 6480464 beryllium sulfate results in decreased expression of CUL9 mRNA CTD PMID:35679967 Cul9 Rat beta-lapachone decreases expression ISO CUL9 (Homo sapiens) 6480464 beta-lapachone results in decreased expression of CUL9 mRNA CTD PMID:38218311 Cul9 Rat bis(2-ethylhexyl) phthalate increases expression ISO Cul9 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CUL9 mRNA CTD PMID:34319233 Cul9 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CUL9 mRNA CTD PMID:25181051 Cul9 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:36041667 Cul9 Rat bisphenol A multiple interactions ISO CUL9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CUL9 gene CTD PMID:31601247 Cul9 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CUL9 mRNA CTD PMID:30816183 Cul9 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CUL9 gene CTD PMID:28505145 Cul9 Rat bisphenol F multiple interactions ISO CUL9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CUL9 mRNA CTD PMID:28628672 Cul9 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:36041667 Cul9 Rat bisphenol F decreases expression ISO Cul9 (Mus musculus) 6480464 bisphenol F results in decreased expression of CUL9 mRNA CTD PMID:38685157 Cul9 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CUL9 mRNA CTD PMID:33453195 Cul9 Rat carbon nanotube decreases expression ISO Cul9 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CUL9 mRNA CTD PMID:25554681 Cul9 Rat CGP 52608 multiple interactions ISO CUL9 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CUL9 gene] CTD PMID:28238834 Cul9 Rat cisplatin multiple interactions ISO CUL9 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CUL9 mRNA CTD PMID:27392435 Cul9 Rat dexamethasone decreases expression ISO CUL9 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of CUL9 mRNA CTD PMID:25047013 Cul9 Rat dexamethasone multiple interactions ISO CUL9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CUL9 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:28628672 Cul9 Rat Dibutyl phosphate affects expression ISO CUL9 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CUL9 mRNA CTD PMID:37042841 Cul9 Rat doxorubicin decreases expression ISO CUL9 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CUL9 mRNA CTD PMID:29803840 Cul9 Rat ethanol affects splicing ISO Cul9 (Mus musculus) 6480464 Ethanol affects the splicing of CUL9 mRNA CTD PMID:30319688 Cul9 Rat ethanol increases expression ISO Cul9 (Mus musculus) 6480464 Ethanol results in increased expression of CUL9 mRNA CTD PMID:30319688 Cul9 Rat ethyl methanesulfonate increases expression ISO CUL9 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of CUL9 mRNA CTD PMID:23649840 Cul9 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CUL9 mRNA CTD PMID:30307764 Cul9 Rat formaldehyde increases expression ISO CUL9 (Homo sapiens) 6480464 Formaldehyde results in increased expression of CUL9 mRNA CTD PMID:23649840 Cul9 Rat FR900359 decreases phosphorylation ISO CUL9 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of CUL9 protein CTD PMID:37730182 Cul9 Rat fulvestrant multiple interactions ISO CUL9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of CUL9 gene CTD PMID:31601247 Cul9 Rat indometacin multiple interactions ISO CUL9 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CUL9 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CUL9 mRNA CTD PMID:28628672 Cul9 Rat methamphetamine increases expression ISO Cul9 (Mus musculus) 6480464 Methamphetamine results in increased expression of CUL9 mRNA CTD PMID:26307267 Cul9 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of CUL9 mRNA CTD PMID:30047161 Cul9 Rat methyl methanesulfonate increases expression ISO CUL9 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CUL9 mRNA CTD PMID:23649840 Cul9 Rat ozone multiple interactions ISO Cul9 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CUL9 mRNA CTD PMID:27106289 and PMID:34911549 Cul9 Rat ozone multiple interactions ISO CUL9 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of CUL9 mRNA CTD PMID:35430440 Cul9 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CUL9 mRNA CTD PMID:32680482 Cul9 Rat propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of CUL9 mRNA CTD PMID:30047161 Cul9 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of CUL9 mRNA CTD PMID:30047161 Cul9 Rat temozolomide increases expression ISO CUL9 (Homo sapiens) 6480464 Temozolomide results in increased expression of CUL9 mRNA CTD PMID:31758290 Cul9 Rat tetrachloromethane decreases expression ISO Cul9 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CUL9 mRNA CTD PMID:25270620 Cul9 Rat tetraphene increases expression ISO Cul9 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of CUL9 mRNA CTD PMID:26377693 Cul9 Rat titanium dioxide decreases expression ISO Cul9 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CUL9 mRNA CTD PMID:23557971 Cul9 Rat titanium dioxide decreases methylation ISO Cul9 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CUL9 gene and titanium dioxide results in decreased methylation of CUL9 promoter CTD PMID:35295148
Cul9 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 9 21,933,699 - 21,977,145 (+) NCBI GRCr8 mRatBN7.2 9 14,435,948 - 14,479,552 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 9 14,436,111 - 14,479,548 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 9 23,019,900 - 23,063,207 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 9 28,082,972 - 28,126,214 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 9 26,383,281 - 26,426,587 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 9 16,747,449 - 16,844,033 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 9 16,747,662 - 16,844,057 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 9 15,652,541 - 15,745,381 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 9 9,800,224 - 9,863,348 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 9 12,185,789 - 12,227,563 (+) NCBI Celera Cytogenetic Map 9 q12 NCBI
CUL9 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 6 43,182,196 - 43,224,587 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 6 43,182,184 - 43,224,587 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 6 43,149,934 - 43,192,325 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 6 43,257,900 - 43,300,303 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 6 44,702,143 - 44,744,534 (+) NCBI Celera Cytogenetic Map 6 p21.1 NCBI HuRef 6 42,866,612 - 42,909,021 (+) NCBI HuRef CHM1_1 6 43,152,810 - 43,195,260 (+) NCBI CHM1_1 T2T-CHM13v2.0 6 43,010,969 - 43,053,382 (+) NCBI T2T-CHM13v2.0
Cul9 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 17 46,811,535 - 46,857,314 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 17 46,811,498 - 46,857,314 (-) Ensembl GRCm39 Ensembl GRCm38 17 46,500,609 - 46,546,388 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 17 46,500,572 - 46,546,388 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 17 46,637,554 - 46,683,337 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 17 45,963,794 - 46,009,577 (-) NCBI MGSCv36 mm8 Celera 17 49,936,322 - 49,982,386 (-) NCBI Celera Cytogenetic Map 17 C NCBI cM Map 17 22.9 NCBI
Cul9 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955437 9,109,889 - 9,147,526 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955437 9,109,997 - 9,145,181 (+) NCBI ChiLan1.0 ChiLan1.0
CUL9 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 5 57,682,085 - 57,724,502 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 6 53,551,886 - 53,594,307 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 6 42,773,955 - 42,816,361 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 6 44,067,392 - 44,110,122 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 6 44,067,389 - 44,110,122 (+) Ensembl panpan1.1 panPan2
CUL9 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 12 11,674,408 - 11,714,578 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 12 11,676,271 - 11,714,578 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 12 11,701,389 - 11,741,555 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 12 12,156,979 - 12,196,916 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 12 12,157,064 - 12,196,913 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 12 11,684,308 - 11,724,237 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 12 11,768,727 - 11,808,627 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 12 11,863,521 - 11,903,458 (+) NCBI UU_Cfam_GSD_1.0
Cul9 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404946 47,180,814 - 47,216,985 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936476 16,743,202 - 16,779,298 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936476 16,743,221 - 16,779,293 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CUL9 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 7 38,224,332 - 38,263,425 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 7 38,224,023 - 38,263,429 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 7 43,724,604 - 43,763,789 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CUL9 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 17 28,928,167 - 28,982,924 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 17 28,927,967 - 28,982,483 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666044 43,241,772 - 43,286,520 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cul9 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 65 Count of miRNA genes: 63 Interacting mature miRNAs: 65 Transcripts: ENSRNOT00000028786 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
631211 Bw4 Body weight QTL4 5.31 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 9 5109826 50109826 Rat 2303559 Gluco54 Glucose level QTL 54 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 9 1254084 46254084 Rat 7411609 Foco16 Food consumption QTL 16 25.6 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 9 8952560 53952560 Rat 61450 Ciaa3 CIA Autoantibody QTL 3 6.5 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 9 7954720 22071169 Rat 9589055 Scfw5 Subcutaneous fat weight QTL 5 5.55 0.001 subcutaneous adipose mass (VT:1000472) abdominal subcutaneous fat pad weight (CMO:0002069) 9 1 37999212 Rat 1641911 Alcrsp13 Alcohol response QTL 13 response to alcohol trait (VT:0010489) brain neurotensin receptor 1 density (CMO:0002068) 9 1 43718459 Rat 1354650 Despr5 Despair related QTL 5 4.01 0.0017 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 9 1254084 46254084 Rat 1300124 Cm4 Cardiac mass QTL 4 3.55 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 9 1 40594091 Rat 61425 Cia15 Collagen induced arthritis QTL 15 4.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 9 5109826 42921101 Rat 70226 Eae4 Experimental allergic encephalomyelitis QTL 4 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 9 1 25661317 Rat 9589158 Gluco65 Glucose level QTL 65 6.82 0.001 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 9 1 37999212 Rat 10054125 Srcrt7 Stress Responsive Cort QTL 7 3.33 0.0011 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 9 1 87073594 Rat 1600365 Mcs20 Mammary carcinoma susceptibility QTL 20 3 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 9 13533770 42791750 Rat 11353947 Bp392 Blood pressure QTL 392 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 9 7283252 52283252 Rat 7411592 Foco8 Food consumption QTL 8 7.4 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 9 1 37999212 Rat 1331757 Cdexp1 CD45RC expression in CD8 T cells QTL 1 4.3 CD8-positive T cell quantity (VT:0008077) blood CD45RC(high) CD8 T cell count to CD45RC(low) CD8 T cell count ratio (CMO:0001990) 9 1024537 67509080 Rat 1298088 Edpm11 Estrogen-dependent pituitary mass QTL 11 2.5 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 9 1 43718459 Rat 9589133 Insul26 Insulin level QTL 26 17.96 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 9 8952560 53952560 Rat
BE113130
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 9 14,470,606 - 14,470,766 (+) MAPPER mRatBN7.2 Rnor_6.0 9 16,835,092 - 16,835,251 NCBI Rnor6.0 Rnor_5.0 9 15,736,436 - 15,736,595 UniSTS Rnor5.0 RGSC_v3.4 9 9,854,235 - 9,854,394 UniSTS RGSC3.4 Celera 9 12,218,624 - 12,218,783 UniSTS RH 3.4 Map 9 59.4 UniSTS Cytogenetic Map 9 q12 UniSTS
BF413122
Rat Assembly Chr Position (strand) Source JBrowse RGSC_v3.4 9 9,826,042 - 9,826,182 UniSTS RGSC3.4 Celera 9 12,209,520 - 12,209,660 UniSTS RH 3.4 Map 9 58.9 UniSTS Cytogenetic Map 9 q12 UniSTS
RH135253
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 9 14,437,626 - 14,437,807 (+) MAPPER mRatBN7.2 Rnor_6.0 9 16,749,119 - 16,749,299 NCBI Rnor6.0 Rnor_5.0 9 15,654,071 - 15,654,251 UniSTS Rnor5.0 RGSC_v3.4 9 9,799,533 - 9,799,713 UniSTS RGSC3.4 Celera 9 12,185,128 - 12,185,308 UniSTS RH 3.4 Map 9 55.0 UniSTS Cytogenetic Map 9 q12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000028786 ⟹ ENSRNOP00000028786
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 9 16,749,809 - 16,843,910 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000080815 ⟹ ENSRNOP00000073679
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 9 14,436,111 - 14,479,548 (+) Ensembl Rnor_6.0 Ensembl 9 16,747,662 - 16,844,057 (+) Ensembl
RefSeq Acc Id:
NM_001191582 ⟹ NP_001178511
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,803 - 21,977,145 (+) NCBI mRatBN7.2 9 14,436,199 - 14,479,547 (+) NCBI Rnor_6.0 9 16,749,809 - 16,844,033 (+) NCBI Rnor_5.0 9 15,652,541 - 15,745,381 (+) NCBI Celera 9 12,185,789 - 12,227,563 (+) NCBI
Sequence:
ATGGTAGGAGAACAGCGAGCAGGGGACCTTATGGTACCCTTGGGGCCTCGGCTGCAGGCATACCCTGAAGAACTCATTCGGCAGAGACCTGGACATGACGGCCATCCTGAATACCTGATCCGTTGGCG TGTCCTCAAGTGTAGCGAAGAGGGCAAAGTGAGCTTAGAGGAGGAGAAGACAGAGTACCTCCTCATGTGGCTGTCAGCCCCAGAGGTCTATGCCAACTGCCCCATGCTACTTCGGGAACGATCAGTGT CTAAAGGCCCACAGTACGAACCCACCGGAGAGGTGGGGAGCTTCCCACGAGACCCAGGAGGCCTGGACGAGTTGGCAATGGCAGAGATGGAGGACGATGTGCGGGCGCTGGTGCGCAGGGCTGCCAGG CAGCTGGCAGAAGGTGGGGCCTCCAACCTGACGGTTGCTGTGCTTCATACCATCCACGTGCTCAGTGCCTATGCCAGCATTGGGCCTCTCACCGGGGTCTTCAGGGAGACAGGAGCCCTGGATCTGCT AATGCACATGCTGTGCAGTCCGGAGCCTCAGATCCGTCGGAGTGCAGGCAAGATGCTACAGGCTCTGGCAGCCCATGATGCTGGGAGCCGGGCTCACGTCCTTCTGTCACTGAGCCAACATGAGGGCA TCGAGCAACACATGGATTTTGACAGCCGCTACACTTTACTGGAGCTGTTCGCAGAGACCACGTCCACGGAGGAGCACTGCATGGCCTTGGAGGGCATCCACCTTCCTCAGCTCCCTGGGAAGCTGCTC TTCTCCCTGGTGAAACGCTACCTATGTGTCACGTCCCTGCTGGATCAGCTGAATAACAGCCCAGAGTCAGGAGCTGGAGACCAGAGCTCTCCGTGTCTCCCAAAGGAGAAGAGTCGGGGACAGCGGGA GCTGGAGTTCAGTATGGCGGTGGGCAACCTCATTTCAGAGCTGGTGCGGAGCATGGGCTGGGCGCGGAACCTCAGTGAGCAGGGCGCCTTGCCGCCCCGGCCTTCCCGGTCCATCTTCCAGCCGTGCC TCTCAGGCCCTCCACTGCTGCTGCCCACCATCGTCACTACGCCCAGGAAGCCAGGACGGGCCTTCCGCGGCCGTTCTGAATTTTCCAGCCGCAGTGGTTACGGTGAATATGTTCAGCAGACGGTGCAG CCCGGCATGCGCGTTCGCATCCTGGATGACTACGAAGAGATCAGTGCTGGGGACGAGGGCGAGTTCCAGCAGAGCAACAATGGCGTGCCTCCTGTGCAGGTCTTCTGGCAGTCAACCGGCCGCACCTA CTGGGTCCACTGGCACATGCTAGAGATCCTGGGGCCTGAGGAAGCCACTAGGGAGCCAGCATCAGCAGCTGTGGAGAAGGGAGCAGGGGCAACTGCCCTGGGCACAGCGTGTCCCTCCTGGGACAGGA AGCCAGCGCATGGCCTCTACTCACTACCGTATCTACAGCCCGAGTCCCAGAAGAGCGAGGAGCCAGGGTACCTGACCCAGGGAGAGTGGTGGGAGCTACTTTTCTTCATCAAGAAGTTGGACTTGTGT GAGCAGCAGCCAATTTTCCAGAATCTGCATGAGAAACTGGATAAGGAGGCCGTGGGAGAAAAGACTCTGGGAGAGATCTCTGTGCCCATAGAGATGGCTGAGGGTGTGCTGCAGGTTCTCAGTAACCG CTTTGAGGGCAGCAACCTCTGTGACCTGCTCAACTCCCACATCTACACCAAGTACGGACGGCTGCCCAAGGAACCAGGGCGCTTACCGCCTTCACGGGGTCACTCCTGTACCTCCGAGCCAGAGGAGG GGTCGGAGTCAGCCGCCAGCTTCTCAGAGAAGGAAGAGTCCCCAAAGGCAGAGGCGGAGCCCGCAGGCGCAAAGCCGGAGTCCCCCAAAGCACAGAGCGACTCCCAGCTGTTCAATCAGCTTCTGGTG ACTGAGGGGATGGCTCTGGCCCCTGAAACACAGGCGGCAGCTACTGAAATGGCCAGAACCTTGCGGGGTCCCGGTCCACGCAGCTCCCTGGATCAGCATGTGGCAGCCGTCTTAGCCACTGTGCAGAT CTCCAGCCTGGATACAAACCTGCAGCTTTCAGGGCTCGGTGCCCTCTCCCAGGCGGTGGAGGAGGTCACTGAGCGGGACCACCCTCTGGTCCGTCCTGACAGATCCTTGAGAGAGAAGCTCGTGAAGA CCCTGGTGGATTTGCTGACCAACCAGGTGGGAGAGAAGATGGTGGTGGTGCTGGCCCTGCGCCTCCTCTACCTGCTCATGACCAAGCATGAATGGCGTCCGCTCTTTGCCAGGGAGGGTGGCATCTAC GCTGTGCTGATCTGCATGCAAGAATACAAGACATCTGTCTTGGTGCAGCAGGCGGGACTGGCAGCGCTAAAGATGCTAGCCATTGCTAATTCCTCCGAGGTGCCCACTTTTGTCACCGGCCGAGATTC CATCCAGCCTCTGTTTGATACCCAGATGACCAGAGAGATCTTTGCCAGCATTGACTCTGCCACACGTCCAGGCTCTGAGAGCTTGCTCCTCAGTGTACCCGCAGCCGTGGTCCTGATGCTGAATACCG AGGGGTGCTCCTCTGCAGTGAGAAATGGCCTGCTGCTACTCAACCTGCTTCTGTGTAACCACCACACTCTGGGAGACCAGATCATAACCCAGGAGCTGAGAGACACCTTGTTCAGGCACTCAGGGATA GCGCCGGGGACAGAACCAATGCCCACCACACGCACCATCCTCATGATGCTTCTCAGTCGCTACTCAGAGCCTTGGGGAAGTCCTGAGCGAGCAGCACTGGAGACCCCAAGCACCCAGGGTCAGGATGG GTCCCCTGAGTCACTCATCCGATCTCTGGTGGGGGACCTGTCAGCAGAACTCTTCCTGGACTTGGAGCGTGTTCTGTGCCACGAAGGCAGCCCTCAAGGTGCCATGACGCCCCTCCTCAAGCGCCTCC AGCAGGAAACACAGCCTTTCCTTCTGTTGCTGCGGACTCTAGATGCCCCTGGGCCCAACAGAGCTCTGCTGCTCACCGTACTCAGGGTCATGACACGACTACTGGATTATCCTGAGACAATGGTTCTC CCCTGGCACGAGGTCTTGGAGCCCTGCCTCAACTGCCTGAATGGGCCAAGCAGTGACTCTGAGGTTGTCCAGGAACTGACCTGCTTCCTGCACCGCCTGGCTCTGATGCACAAAGACTATGCGGTAGT GCTTTGCTGCCTGGGAGCCAAAGAAGCCCTCTCCAAAGTCCTGGACAAGCACTCCACTCAGCTCCTGCTGGCCTCGGAGCTCCGCCACCTGGTGACGGAGTGCGAGAAGTACGCCCAGCTCTACACTA ACCTCACCTCGAGCCTCCTGGCTGCCTGCATCCAGATGGTGCTGGGCCAGATTGAAGACCACAGGCGAACCTACAAGCCCATCAACATCCCCTTCTTTGATGTGTTCCTCAGGCATCTCTGCCAGGGC TCCAGTGTGGAAGTGAAGGAAGACAGGTGCTGGGAGAAGGTGGAGGTGTCCTCCAATCCACACCGGGCCAGCAAGCTGACGGACCGCAATCCCAAGACCTACTGGGAGTCCAACGGCAGCACTGGCTC CCACTCCATCACCTTGCACATGCACCGTGGTGTTCTTATTAGGCAGCTGACCTTGCTTGTGGCCAGTGAGGATTCAAGTTACATGCCAGCCAGGGTGGTGGTGTTTGGGGGTGACAGTGTTGGCTGCA TCAGCACCGAACTTAACACGGTGAATGTGGTGCCCTCTGCCAGCCGGGTGACACTCCTGGAGAACCTCAGCCGCTTCTGGCCCATCATCCAGATCCGAATAAAGCGCTGTCAGCAGGGCGGCATCGAC ACTCGAGTTCGGGGTGTGGAGGTGCTGGGCCCCAAGCCCACCTTCTGGCCATTGTTCCGGGAGCAACTCTGCCGACGGACTTGTCTCTTCTACACAATTCGGGCACAAGCATGGAGCCGGGACATAGC AGAGGACCGCCAGCGCCTCCTTCAGCTCTATCCTAGACTGAACAGAGTTTTACGCCATGAACAGAATTTTGCAGATCGCTTCCTCCCTGATGATGAGGCTGCCCAAGCACTGGGCAAAACCTGCTGGG AGGCGCTGGTCAGCCCCCTGGTGCAGAACATCACCTCTCCCGATGCAGGGGGTGTGAGTTCCCTGGGATGGCTGCTGGACCAGTACCTGGAGCACAGGGAGAAAGCGAGGAGCCGCCAGGGTCAGGCA GCATCCTTTGCTTCTCAAGTTCGGCGCTTATGCCACTTGCTGGTACACGTGGAAGCCCCTCCTGGGCCTTCTCCTGAGCCGTCCTCGCAGCCCCTCAGCAAGAGCAGTAAGAGTCAGGACGGAAGCCC GGCCCCGGCCCCCGTCCGCCCCAGCACCACCCTTAGGAACATCACCCAGTGCTGGCTGGCGGTGGTGCAGGGACAGGCCAGCAGATTCCTGGCCTCAGCCTGGAGGGCCTCGGACTTCGTGCCTCGCT ACTGTGATCTCTACGAGCGCTTGCAAAGAGCCGGCTCAGAGCTGTTCGGGCCGCGGGCAGCCTTCACCCTGGCCCTGCGCAGCGGCTTCTCTGGGGCTCTGCTGCAGCAGTCCTTCCTCACTGCTGCT CACATAAGTGAGCAGTTTGCGAGGCACATTGACCAGCAGATCCAGGGTGGTTTGCTTGGTGGAGCTGCTGGGGTGGAAATGCTGGGGCGGCTTCAGCGGCACCTGGAGCCCATCATGGTCCTTTCTGG CCTAGAGCTGGCCACTACTTTTGAGCACTTCTATCAGTACTACATGGCTGACAGGCTCCTGAGCTTGGGCTCGAGCTGGCTGGAGGGGGCCGTGCTGGAGCAGATTGGCCTCTGCTTCCCCAACCGCC TCCCCCAGCTGATGCTGCAGAGCCTGCGCACCTCAGAGGAGCTGCAGCGTGGGTTCCTCCTCTTCCAGCTCCAGCAGCTCGACCGGCAGCTCTTGGAGCAGGGGGAGCAGGAGGAATGGAAGCTAGAG AGACTGGAGGAAGAAGACAGGGGACAGGAGACTGGAAGAGAACTCCTTACAGAAGACCCAGGACCAGCCATTTCTGTCCTGGTCCTGTCACCGCGCTGCTGGCCGGTCTCCCCACTGTGCTACCTGCA CCAGCCCAGGAAGCACCTTCCCACGGAGTTCTGTGATGCCCTTGACGGCTTCTCCAGCTTCTACAGCCACAGTCAGCACTACCCAGTCTTGGACATGGGACCACATCGGCGACTTCAGTGGACATGGC TGGGCCGGGCTGAGCTGCAGTTTGGGGACCAGACCCTGCATGTGTCCACTGTGCAGATGTGGCTGCTGCTGAATTTCAACCAGACAGAGGAGGTGTCAGTAGAGATCTTGTTGAGGAACTCTGGCCTC TCCCCTGAGCTCCTGCACCAGGCCCTTCTGCCGCTCACCTCAGACAGTGGTCCCTTAACACTGGAGGAGGCTCAGGACTTTCCACAGGGGGGGGTGCTGCGGCTTCGTGAGCCTAGGTCCCAGACCCA TGAAGAGGTCCTGTGGCTGATACCTCCCCAGACGTATCTCAGTGTGGAAAAGGATGAGGGCCGAACCTTGGAGCAGAAGAGGAACCTCTTGAGCTGCCTTCTCGTACGGATACTCAAAGCCCACGGGG AGAAAGGCCTGCACATCGATCAGCTGGTTTGTCTGGTTCTGGAGGCCTGGCAGAAGGGGCCAAATCCACCGGGGCGCCTGGGCCGCTCTGCTGCAGTGGGCGTGGCCTGTTCCAGCACTGACGTCCTC TCTTGTATCCTGCATCTCCTGGGCCAGGGCTACGTGGAGCGGAGAGATGACCGACCTCAGGTCCTGATGTATGCCACCCCAGAGCCCATGGGGCACTGCCGGGGCCAGGCAGATGTCCCCTTTTGTGG CAACCAGAGCACGGAGACCTCCAAACCTAGCCCAGAAGCTGTGGTGGCCCTGGCCTCTCTGCAGCTGCCGGCAGGCCGGACCATGAGTCCCCAGGAGGTAGAAGGATTGATGGAGCAGACAGTGCGGC AGGTGCAGGAGACGCTGAACTTGGAGCCCGATGTGGCTCAGCACCTTCTGGCTTATTCCCACTGGGGCACGGAGCAGCTGCTACAAAGCTACAGCGAGGATCCCGAGCCACTGCTGCTCGCCGCAGGG CTGCGAGTGCCCCAGCCCCAGGAGGTGCCCGCTCGCCCTGACCAGTGCCCCGTGTGCATCAGCCCCCTAGGGCCCAATGACGACTCGCCCTCCCTCTGCTGCCTGCACTGCTGCTGTAAGTCTTGCTG GAACGAGTACCTGACGACTCGGATAGAGCAGAACTTTGTGCTGAACTGTACCTGCCCCATCGCTGACTGTCCCGCCCAGCCCACGGGAGCCTTCATCCGAAACATTGTCTCTTCCCCAGAGGTCATCT CCAAGTATGAGAAGGCCCTTCTGCGAGGTTATGTGGAGAGCTGCTCCAACCTGACATGGTGCACCAACCCTCAGGGCTGCGACCGTATCCTGTGCCGCCAGGGCCTGGGCAGTGGGACCACCTGCTCT AAGTGCGGCTGGGCCTCTTGCTTCAACTGTAGTTTTCCTGAGGCGCACTATCCTGCCAGCTGTGGCCACATGTCCCAGTGGGTTGACGATGGCGGCTACTATGACGGCATGAGCGTGGAGGCCCAGAG CAAGCACCTGGCCAAGCTCATCTCCAAACGCTGTCCCAGCTGTCAGGCGCCTATCGAGAAGAATGAGGGGTGTCTACACATGACCTGTGCAAGATGTAACCATGGGTTCTGCTGGCGCTGCCTCAGGT CCTGGAAGCCAAGCCACAAGGACTACTACAACTGCTCTGCCATGGTAAGCAAAGCAGCTCGCCAGGAGAAGCGGTTTCAGGACTATAACGAGAGGTGTACCTTCCACCACCAGGCCCGGGAGTTTGCT GTCAACCTGCGGAACCAGGCCTCTGCCATCCATGAGGTGCCTCCGCCCAAATCCTTCACCTTCCTGCAAGACGCCTGCCGGGCCCTCGAGCAGGCTCGAAAGGTGCTGGCCTACGCCTGTGTCTATAG CTTCTACAGCCAGGGCACGGAGTACATGGATGTGGTGGAGCAGCAGACGGAGAACCTGGAGCTGCACACGAATGCCCTGCAGATCCTCCTCGAGGAGACCTTGCTGCGCTGCCAGGACCTGGCCTCCT CCCTGCGCCTCCTGCGGGCTGACTGCCTCAGCACAGGCACGGAGTTGCTCCGGAGGATCCAGGAGAGGCTGTTGGCCATCCTACAGCACTCGACCCAGGACTTCCGGGTCGGGCTGCAGAGTCCCTCA GTAGAGACCCGGGAGGTGAAAGGGTCCAACGTGCCCAGTGACCAGCCCCAGGGCTCCTCAGGACTGGAAGTGGAAGACGAGGAGGAAGAAGAGGAAGAGGAGGAGGAGGAGGATGTACCTGAGTGGCA GCACGAGTTTGATGAGGAACTAGACAATGACAGCTTCTCCTACGATGAGGAGTCTGAGAACCTGGACCGAGAGACCTTCTTCTTTGGCGATGAAGATGACGATGATGAGTCCTATGACTGAGGGGGAG GGGCAGGAAACACCTGGAGCTGCCGGGGCAGCAGGGCCACGGGGCTGTCATGTGAGAGGGGAACCCCAGTGTCTGAAGCACCTTCTGTTTACTGAATAAACCTCTTTTTTCACACAC
hide sequence
RefSeq Acc Id:
XM_039083508 ⟹ XP_038939436
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,977,145 (+) NCBI mRatBN7.2 9 14,435,954 - 14,479,552 (+) NCBI
RefSeq Acc Id:
XM_039083509 ⟹ XP_038939437
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,977,145 (+) NCBI mRatBN7.2 9 14,435,953 - 14,479,552 (+) NCBI
RefSeq Acc Id:
XM_039083510 ⟹ XP_038939438
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,977,145 (+) NCBI mRatBN7.2 9 14,435,951 - 14,479,552 (+) NCBI
RefSeq Acc Id:
XM_039083511 ⟹ XP_038939439
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,706 - 21,977,145 (+) NCBI mRatBN7.2 9 14,435,952 - 14,479,552 (+) NCBI
RefSeq Acc Id:
XM_039083512 ⟹ XP_038939440
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,973,499 (+) NCBI mRatBN7.2 9 14,435,951 - 14,475,898 (+) NCBI
RefSeq Acc Id:
XM_063267094 ⟹ XP_063123164
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,977,145 (+) NCBI
RefSeq Acc Id:
XR_005488889
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,973,497 (+) NCBI mRatBN7.2 9 14,435,950 - 14,477,012 (+) NCBI
RefSeq Acc Id:
XR_005488890
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,699 - 21,967,916 (+) NCBI mRatBN7.2 9 14,435,948 - 14,470,316 (+) NCBI
RefSeq Acc Id:
XR_005488891
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,967,916 (+) NCBI mRatBN7.2 9 14,435,955 - 14,470,316 (+) NCBI
RefSeq Acc Id:
XR_010054591
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 9 21,933,702 - 21,969,429 (+) NCBI
RefSeq Acc Id:
NP_001178511 ⟸ NM_001191582
- Sequence:
MVGEQRAGDLMVPLGPRLQAYPEELIRQRPGHDGHPEYLIRWRVLKCSEEGKVSLEEEKTEYLLMWLSAPEVYANCPMLLRERSVSKGPQYEPTGEVGSFPRDPGGLDELAMAEMEDDVRALVRRAAR QLAEGGASNLTVAVLHTIHVLSAYASIGPLTGVFRETGALDLLMHMLCSPEPQIRRSAGKMLQALAAHDAGSRAHVLLSLSQHEGIEQHMDFDSRYTLLELFAETTSTEEHCMALEGIHLPQLPGKLL FSLVKRYLCVTSLLDQLNNSPESGAGDQSSPCLPKEKSRGQRELEFSMAVGNLISELVRSMGWARNLSEQGALPPRPSRSIFQPCLSGPPLLLPTIVTTPRKPGRAFRGRSEFSSRSGYGEYVQQTVQ PGMRVRILDDYEEISAGDEGEFQQSNNGVPPVQVFWQSTGRTYWVHWHMLEILGPEEATREPASAAVEKGAGATALGTACPSWDRKPAHGLYSLPYLQPESQKSEEPGYLTQGEWWELLFFIKKLDLC EQQPIFQNLHEKLDKEAVGEKTLGEISVPIEMAEGVLQVLSNRFEGSNLCDLLNSHIYTKYGRLPKEPGRLPPSRGHSCTSEPEEGSESAASFSEKEESPKAEAEPAGAKPESPKAQSDSQLFNQLLV TEGMALAPETQAAATEMARTLRGPGPRSSLDQHVAAVLATVQISSLDTNLQLSGLGALSQAVEEVTERDHPLVRPDRSLREKLVKTLVDLLTNQVGEKMVVVLALRLLYLLMTKHEWRPLFAREGGIY AVLICMQEYKTSVLVQQAGLAALKMLAIANSSEVPTFVTGRDSIQPLFDTQMTREIFASIDSATRPGSESLLLSVPAAVVLMLNTEGCSSAVRNGLLLLNLLLCNHHTLGDQIITQELRDTLFRHSGI APGTEPMPTTRTILMMLLSRYSEPWGSPERAALETPSTQGQDGSPESLIRSLVGDLSAELFLDLERVLCHEGSPQGAMTPLLKRLQQETQPFLLLLRTLDAPGPNRALLLTVLRVMTRLLDYPETMVL PWHEVLEPCLNCLNGPSSDSEVVQELTCFLHRLALMHKDYAVVLCCLGAKEALSKVLDKHSTQLLLASELRHLVTECEKYAQLYTNLTSSLLAACIQMVLGQIEDHRRTYKPINIPFFDVFLRHLCQG SSVEVKEDRCWEKVEVSSNPHRASKLTDRNPKTYWESNGSTGSHSITLHMHRGVLIRQLTLLVASEDSSYMPARVVVFGGDSVGCISTELNTVNVVPSASRVTLLENLSRFWPIIQIRIKRCQQGGID TRVRGVEVLGPKPTFWPLFREQLCRRTCLFYTIRAQAWSRDIAEDRQRLLQLYPRLNRVLRHEQNFADRFLPDDEAAQALGKTCWEALVSPLVQNITSPDAGGVSSLGWLLDQYLEHREKARSRQGQA ASFASQVRRLCHLLVHVEAPPGPSPEPSSQPLSKSSKSQDGSPAPAPVRPSTTLRNITQCWLAVVQGQASRFLASAWRASDFVPRYCDLYERLQRAGSELFGPRAAFTLALRSGFSGALLQQSFLTAA HISEQFARHIDQQIQGGLLGGAAGVEMLGRLQRHLEPIMVLSGLELATTFEHFYQYYMADRLLSLGSSWLEGAVLEQIGLCFPNRLPQLMLQSLRTSEELQRGFLLFQLQQLDRQLLEQGEQEEWKLE RLEEEDRGQETGRELLTEDPGPAISVLVLSPRCWPVSPLCYLHQPRKHLPTEFCDALDGFSSFYSHSQHYPVLDMGPHRRLQWTWLGRAELQFGDQTLHVSTVQMWLLLNFNQTEEVSVEILLRNSGL SPELLHQALLPLTSDSGPLTLEEAQDFPQGGVLRLREPRSQTHEEVLWLIPPQTYLSVEKDEGRTLEQKRNLLSCLLVRILKAHGEKGLHIDQLVCLVLEAWQKGPNPPGRLGRSAAVGVACSSTDVL SCILHLLGQGYVERRDDRPQVLMYATPEPMGHCRGQADVPFCGNQSTETSKPSPEAVVALASLQLPAGRTMSPQEVEGLMEQTVRQVQETLNLEPDVAQHLLAYSHWGTEQLLQSYSEDPEPLLLAAG LRVPQPQEVPARPDQCPVCISPLGPNDDSPSLCCLHCCCKSCWNEYLTTRIEQNFVLNCTCPIADCPAQPTGAFIRNIVSSPEVISKYEKALLRGYVESCSNLTWCTNPQGCDRILCRQGLGSGTTCS KCGWASCFNCSFPEAHYPASCGHMSQWVDDGGYYDGMSVEAQSKHLAKLISKRCPSCQAPIEKNEGCLHMTCARCNHGFCWRCLRSWKPSHKDYYNCSAMVSKAARQEKRFQDYNERCTFHHQAREFA VNLRNQASAIHEVPPPKSFTFLQDACRALEQARKVLAYACVYSFYSQGTEYMDVVEQQTENLELHTNALQILLEETLLRCQDLASSLRLLRADCLSTGTELLRRIQERLLAILQHSTQDFRVGLQSPS VETREVKGSNVPSDQPQGSSGLEVEDEEEEEEEEEEEDVPEWQHEFDEELDNDSFSYDEESENLDRETFFFGDEDDDDESYD
hide sequence
Ensembl Acc Id:
ENSRNOP00000073679 ⟸ ENSRNOT00000080815
Ensembl Acc Id:
ENSRNOP00000028786 ⟸ ENSRNOT00000028786
RefSeq Acc Id:
XP_038939438 ⟸ XM_039083510
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_038939440 ⟸ XM_039083512
- Peptide Label:
isoform X6
RefSeq Acc Id:
XP_038939439 ⟸ XM_039083511
- Peptide Label:
isoform X5
RefSeq Acc Id:
XP_038939437 ⟸ XM_039083509
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_038939436 ⟸ XM_039083508
- Peptide Label:
isoform X1
- UniProtKB:
A0A0G2K652 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063123164 ⟸ XM_063267094
- Peptide Label:
isoform X4
RGD ID: 13696517
Promoter ID: EPDNEW_R7041
Type: multiple initiation site
Name: Cul9_1
Description: cullin 9
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 9 16,747,678 - 16,747,738 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2010-04-23
Cul9
cullin 9
Parc
p53-associated parkin-like cytoplasmic protein
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-02-29
Parc
p53-associated parkin-like cytoplasmic protein
RGD1562008_predicted
similar to p53-associated parkin-like cytoplasmic protein (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2006-03-07
RGD1562008_predicted
similar to p53-associated parkin-like cytoplasmic protein (predicted)
LOC316228
similar to p53-associated parkin-like cytoplasmic protein
Symbol and Name status set to approved
1299863
APPROVED
2006-02-09
LOC316228
similar to p53-associated parkin-like cytoplasmic protein
Symbol and Name status set to provisional
70820
PROVISIONAL